Veeva Systems launches AI routing tool for drug safety reports
New York - Veeva Systems, a cloud-based software provider for the life sciences industry, unveiled Falcon Router on Monday. This innovative tool automates the identification and routing of safety adverse event reports, product quality complaints, and medical inquiries for pharmaceutical companies. By managing triage and routing across email and web intake channels, Falcon Router eliminates the need for manual intervention, directing information to Veeva Safety, Veeva QMS, Veeva MedInquiry, or designated inboxes.
The launch of Falcon Router is set for early adopter availability in January 2027, part of Veeva’s Falcon Agent Suite, which aims to support agentic labor solutions for life sciences firms. John Lawrie, Veeva’s vice president of Safety, emphasized that every biopharma faces a routing challenge that increases with the introduction of new regions and products.
He stressed that fast, reliable triage is now more critical than ever, allowing experts to concentrate on what truly matters—the patient. Veeva, headquartered in Pleasanton, California, serves over 1,500 customers, including major pharmaceutical companies and biotechnology firms.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
